Ming Zhao - China Jo Chief Officer
CJJD Stock | USD 1.59 0.06 3.64% |
Executive
Mr. Ming Zhao is Chief Financial Officer of China JoJo Drugstores, Inc. From September 2010 to July 2011, Mr. Zhao was a senior manager at CFO Oncall, Inc., a financial consulting firm providing CFO services to U.S.listed, Chinabased publicly traded companies. From December 2006 through August 2010, Mr. Zhao was a senior auditor at Sherb Co., LLP. From January through June 2003, Mr. Zhao worked as a financial analyst at Microsoft Corporation since 2011.
Age | 49 |
Tenure | 14 years |
Address | Building 5, Hangzhou, China, 310008 |
Phone | 86 57 1882 19579 |
Web | https://www.jiuzhou360.com |
China Jo Management Efficiency
The company has return on total asset (ROA) of (0.0238) % which means that it has lost $0.0238 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.2735) %, meaning that it created substantial loss on money invested by shareholders. China Jo's management efficiency ratios could be used to measure how well China Jo manages its routine affairs as well as how well it operates its assets and liabilities. The current year's Return On Capital Employed is expected to grow to 4.20, whereas Return On Tangible Assets are projected to grow to (17.01). At present, China Jo's Other Assets are projected to decrease significantly based on the last few years of reporting. The current year's Net Tangible Assets is expected to grow to about 17.6 M, whereas Total Current Assets are forecasted to decline to about 47.9 M.Similar Executives
Showing other executives | EXECUTIVE Age | ||
Aidan Clare | Walgreens Boots Alliance | N/A | |
Rick Gates | Walgreens Boots Alliance | 53 | |
Ramita Tandon | Walgreens Boots Alliance | N/A | |
Shimshon JD | High Tide | N/A | |
Tiffany Kanaga | Walgreens Boots Alliance | N/A | |
Wendy Zalai | PetMed Express | N/A | |
Gerald Gradwell | Walgreens Boots Alliance | 56 | |
Elizabeth Burger | Walgreens Boots Alliance | 53 | |
Robyn DElia | PetMed Express | N/A | |
Christine Chambers | PetMed Express | 48 | |
CPA CMA | High Tide | N/A | |
Theresa Mota | SunLink Health Systems | N/A | |
Liyue Wu | Walgreens Boots Alliance | N/A | |
Caroline Conegliano | PetMed Express | N/A | |
Mary Langowski | Walgreens Boots Alliance | N/A | |
Joseph Amsbary | Walgreens Boots Alliance | N/A | |
Jacqueline Smith | PetMed Express | N/A | |
James Mulligan | SunLink Health Systems | 103 | |
John Driscoll | Walgreens Boots Alliance | 65 | |
Beth Leonard | Walgreens Boots Alliance | N/A | |
Sandy Sharma | High Tide | N/A |
Management Performance
Return On Equity | -0.27 | ||||
Return On Asset | -0.0238 |
China Jo Jo Leadership Team
Elected by the shareholders, the China Jo's board of directors comprises two types of representatives: China Jo inside directors who are chosen from within the company, and outside directors, selected externally and held independent of China. The board's role is to monitor China Jo's management team and ensure that shareholders' interests are well served. China Jo's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, China Jo's outside directors are responsible for providing unbiased perspectives on the board's policies.
Yan Liu, Secretary | ||
Lei Liu, Chairman of the Board, CEO | ||
Steve Liu, Investor Director | ||
Lei MD, Chairman CEO | ||
Ming Zhao, Chief Officer |
China Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is China Jo a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
Return On Equity | -0.27 | ||||
Return On Asset | -0.0238 | ||||
Profit Margin | (0.03) % | ||||
Operating Margin | (0.05) % | ||||
Current Valuation | 33.99 M | ||||
Shares Outstanding | 6.18 M | ||||
Shares Owned By Insiders | 38.34 % | ||||
Shares Owned By Institutions | 0.31 % | ||||
Number Of Shares Shorted | 20.66 K | ||||
Price To Earning | (4.60) X |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether China Jo Jo is a strong investment it is important to analyze China Jo's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact China Jo's future performance. For an informed investment choice regarding China Stock, refer to the following important reports:Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in China Jo Jo Drugstores. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in inflation. You can also try the Portfolio Diagnostics module to use generated alerts and portfolio events aggregator to diagnose current holdings.
Is Consumer Staples Distribution & Retail space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of China Jo. If investors know China will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about China Jo listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (3.31) | Revenue Per Share | Quarterly Revenue Growth (0) | Return On Assets | Return On Equity |
The market value of China Jo Jo is measured differently than its book value, which is the value of China that is recorded on the company's balance sheet. Investors also form their own opinion of China Jo's value that differs from its market value or its book value, called intrinsic value, which is China Jo's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because China Jo's market value can be influenced by many factors that don't directly affect China Jo's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between China Jo's value and its price as these two are different measures arrived at by different means. Investors typically determine if China Jo is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, China Jo's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.